RheoDx Conference / February 4th, 2020 (CRM A1 Room)

Jan 24, 2020



General Information

​Date: Tuesday, February 4, 2020

Location: Room A1, Centre de Recerca Matemàtica


How do you pronounce RheoDX? A CRM spin-off? Who is in office C1-014?

Rheo Diagnostics is a startup born in 2018 promoted by the Mobile World Capital Barcelona foundation. Its patented technology is born of the collaboration between the UB and the CRM.

Rheo Diagnostics develops a portable in-vitro diagnosis device for the analysis of the elastic properties of red blood cells and detect abnormalities fast (only takes 5 min) and cheaply with a single drop of blood. The test consists of a microfluidic consumable, a reader system and a cloud server where the data is processed and translated into clinical evidence. It is a device with multiple applications in hematology, from diagnosis to monitoring of patients receiving blood transfusions.

With this activity we intend to give an overview of the company and its trajectory; What is the starting point of the project and its link to the CRM; When and which factors made possible the consolidation of RheoDX and what is our day-to-day life in terms of funding, experimental validation and product, and finally which is our letter to the kings for the next years.


10:15 – 10:25

 Welcome by Lluís Alsedà, Director of the CRM

10:25 – 10:55

 Aurora Hernández-Machado

Tech transfer, from microfluidics theory to a patent.

 10:55 – 11:05


11:05 – 11:25

 Oliver Balcells

How RheoDX connects entrepreneurial and scientific talent to foster innovation.

 11:25 – 11:35


11:35 – 12:00

 Coffee Break

12:00 – 12:20

 Maria Cabello

Tech transfer, from Laboratory to hospitals.

 12:20 –12:30


12:30 – 12:50

 John González

Tech transfer, from technology to a product.

 12:50 – 13:00







The registration is free but due to the capacity of the Room, it is essential to register for the activity by email before January 31st at croca@crm.cat in order to access the Room.